| 000 | 01436 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517194559.0 | ||
| 264 | 0 | _c20190128 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1532-8600 | ||
| 024 | 7 |
_a10.1016/j.metabol.2018.01.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Rui | |
| 245 | 0 | 0 |
_aIL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice. _h[electronic resource] |
| 260 |
_bMetabolism: clinical and experimental _c06 2018 |
||
| 300 |
_a18-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xprevention & control |
| 650 | 0 | 4 |
_aInflammasomes _xdrug effects |
| 650 | 0 | 4 |
_aInsulin Resistance _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aReceptors, Interleukin-6 _xantagonists & inhibitors |
| 700 | 1 | _aLiu, Xuanchen | |
| 700 | 1 | _aYin, Jianyong | |
| 700 | 1 | _aWu, Huijuan | |
| 700 | 1 | _aCai, Xiulei | |
| 700 | 1 | _aWang, Niansong | |
| 700 | 1 | _aQian, Youcun | |
| 700 | 1 | _aWang, Feng | |
| 773 | 0 |
_tMetabolism: clinical and experimental _gvol. 83 _gp. 18-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.metabol.2018.01.002 _zAvailable from publisher's website |
| 999 |
_c27982909 _d27982909 |
||